ClinicalTrials.gg
Sign In

Pancreatitis, Chronic clinical trials

The registry lists 264 studies for Pancreatitis, Chronic across more than 10 countries. 76 are recruiting or about to start. 190 of them are mainly about Pancreatitis, Chronic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its narrower condition Autoimmune Pancreatitis too: 285 studies, 82 open.

Get an email when these change. Save the Pancreatitis, Chronic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
121
Recruiting
49
Status unknown
26
Not yet recruiting
20
Terminated
18
Active, not recruiting
17

Phase

Phase 2
27
Phase 1
20
Phase 3
15
Phase 4
13
Early Phase 1
6

Where

United States
111
China
46
India
17
Denmark
14
Netherlands
12
United Kingdom
11

Who runs them

Changhai Hospital (41) · Asian Institute of Gastroenterology, India (10) · Mayo Clinic (9) · Indiana University (7) · Medical University of South Carolina (6) · University of Michigan (5) · M.D. Anderson Cancer Center (4) · Ohio State University (4)

What is being tested here

Drugs under test in Pancreatitis, Chronic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ringer's Lactate102
Pioglitazone102
Simvastatin112
Pinaverium101
Varenicline101
Pirfenidone101
Semaglutide101
Empagliflozin101
Metformin101
Pancrelipase039

Coming up

1phase 3 study under way
28studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 49 Pancreatitis, Chronic studies recruiting now, 31 (63%) set no upper age limit and 12 (24%) stop at 75 or younger. 8 (16%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 11 (22%) take healthy volunteers.

Recruiting studies that take each age, of 49
AgeWomenMen
105 (10%)5 (10%)
1846 (94%)46 (94%)
3046 (94%)46 (94%)
4046 (94%)46 (94%)
5047 (96%)47 (96%)
6544 (90%)44 (90%)
7542 (86%)42 (86%)
8534 (69%)34 (69%)

Across all 264 studies, recruiting or not: 22% stop at 75 or younger and 9% at 65; 18% take children; <1% are for women only and <1% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pancreatitis, Chronic studies take

Of 58 observational studies under Pancreatitis, Chronic, half reached primary completion within 63 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase32 mo18–64 · 49 studies—32 mo18–64 · 46 studies
Observational63 mo28–160 · 58 studies—87 mo33–160 · 56 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 264. Browse all 264 → or search them.